Bispectral Index Monitoring during Anesthesiologist-Directed Propofol and Remifentanil Sedation for Endoscopic Submucosal Dissection: A Prospective Randomized Controlled Trial
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Endoscopic submucosal dissection (ESD) is a technically difficult and lengthy procedure requiring optimal depth of sedation. The bispectral index (BIS) monitor is a non-invasive tool that objectively evaluates the depth of sedation. The purpose of this prospective randomized controlled trial was to evaluate whether BIS guided sedation with propofol and remifentanil could reduce the number of patients requiring rescue propofol, and thus reduce the incidence of sedation- and/or procedure-related complications. Materials and Methods: A total of 180 patientswho underwent the ESD procedure for gastric adenoma or early gastric cancerwere randomized to two groups. The control group (n=90) was monitored by the Modified Observer’s Assessment of Alertness and Sedation scale and the BIS group (n=90) was monitored using BIS. The total doses of propofol and remifentanil,the need for rescue propofol, and the rates of complications were recorded. Results: The number of patients who needed rescue propofol during the procedure was significantly higher in the control group than the BIS group (47.8% vs. 30.0%, p=0.014). There were no significant differences in the incidence of sedation-and/or procedure-related complications. Conclusion: BIS-guided propofol infusion combined with remifentanil reduced the number of patients requiring rescuepropofol in ESD procedures. However, this finding did not lead to clinical benefits and thus BIS monitoring is of limited use during anesthesiologist-directed sedation.
Abstract
Purpose: Endoscopic submucosal dissection (ESD) is a technically difficult and lengthy procedure requiring optimal depth of sedation. The bispectral index (BIS) monitor is a non-invasive tool that objectively evaluates the depth of sedation. The purpose of this prospective randomized controlled trial was to evaluate whether BIS guided sedation with propofol and remifentanil could reduce the number of patients requiring rescue propofol, and thus reduce the incidence of sedation- and/or procedure-related complications. Materials and Methods: A total of 180 patientswho underwent the ESD procedure for gastric adenoma or early gastric cancerwere randomized to two groups. The control group (n=90) was monitored by the Modified Observer’s Assessment of Alertness and Sedation scale and the BIS group (n=90) was monitored using BIS. The total doses of propofol and remifentanil,the need for rescue propofol, and the rates of complications were recorded. Results: The number of patients who needed rescue propofol during the procedure was significantly higher in the control group than the BIS group (47.8% vs. 30.0%, p=0.014). There were no significant differences in the incidence of sedation-and/or procedure-related complications. Conclusion: BIS-guided propofol infusion combined with remifentanil reduced the number of patients requiring rescuepropofol in ESD procedures. However, this finding did not lead to clinical benefits and thus BIS monitoring is of limited use during anesthesiologist-directed sedation.
참고문헌 (30)
- Imagawa A, "Endoscopic submucosal dissection for early gastric cancer: results and degrees of technical difficulty as well as success", Endoscopy, 38, pp.987~990 (2006)
- Sugimoto T, "Endoscopic submucosal dissection is an effective and safe therapy for early gastric neoplasms: a multicenter feasible study", J Clin Gastroenterol, 46, pp.124~129 (2012)
- Oda I, "Endoscopic submucosal dissection for early gastric cancer: technical feasibility, operation time and complications from a large consecutive series", Dig Endosc, 17, pp.54~58 (2005)
- Sasaki T, "Recommended sedation and intraprocedural monitoring for gastric endoscopic submucosal dissection", Dig Endosc, 25(Suppl 1), pp.79~85 (2013)
- Lee CK, "Balanced propofol sedation for therapeutic GI endoscopic procedures: a prospective, randomized study", GASTROINTESTINAL ENDOSCOPY, 73(2), pp.206~214 (2011), MOSBY-ELSEVIER
- Shah B, "The changing faces of endoscopic sedation", Expert Rev Gastroenterol Hepatol, 4, pp.417~422 (2010)
- Kiriyama S, "Safe and effective sedation in endoscopic submucosal dissection for early gastric cancer: a randomized comparison between propofol continuous infusion and intermittent midazolam injection", J Gastroenterol, 45, pp.831~837 (2010)
- Sasaki T, "Propofol sedation with bispectral index monitoring is useful for endoscopic submucosal dissection: a randomized prospective phase II clinical trial", Endoscopy, 44, pp.584~589 (2012)
- Yamagata T, "Efficacy of propofol sedation for endoscopic submucosal dissection (ESD): assessment with prospective data collection", Intern Med, 50, pp.1455~1460 (2011)
- Mazanikov M, "Patient-controlled sedation with propofol and remifentanil for ERCP: a randomized, controlled study", Gastrointest Endosc, 73, pp.260~266 (2011)
- Hsieh YH, "Propofol alone versus propofol in combination with meperidine for sedation during colonoscopy", J Clin Gastroenterol, 43, pp.753~757 (2009)
- Külling D, "Safer colonoscopy with patient-controlled analgesia and sedation with propofol and alfentanil", Gastrointest Endosc, 54, pp.1~7 (2001)
- Bell JK, "Bispectral index monitoring for conscious sedation in intervention: better, safer, faster", Clin Radiol, 59, pp.1106~1113 (2004)
- Imagawa A, "Satisfaction with bispectral index monitoring of propofol-mediated sedation during endoscopic submucosal dissection: a prospective, randomized study", Endoscopy, 40, pp.905~909 (2008)
- Ki Joo Kang, "Efficacy of Bispectral Index Monitoring for Midazolam and Meperidine Induced Sedation during Endoscopic Submucosal Dissection: A Prospective, Randomized Controlled Study", Gut and Liver, 5(2), pp.160~164 (2011), 거트앤리버 발행위원회
- von Delius S, "Bispectral index monitoring of midazolam and propofol sedation during endoscopic retrograde cholangiopancreatography: a randomized clinical trial (the EndoBIS study)", Endoscopy, 44, pp.258~264 (2012)
- Paspatis GA, "Efficacy of bispectral index monitoring as an adjunct to propofol deep sedation for ERCP: a randomized controlled trial", Endoscopy, 41, pp.1046~1051 (2009)
- Drake LM, "Efficacy of bispectral monitoring as an adjunct to nurse-administered propofol sedation for colonoscopy: a randomized controlled trial", Am J Gastroenterol, 101, pp.2003~2007 (2006)
- von Delius S, "Auditory evoked potentials compared with bispectral index for monitoring of midazolam and propofol sedation during colonoscopy", Am J Gastroenterol, 104, pp.318~325 (2009)
- Johansen JW, "Update on bispectral index monitoring", Best Pract Res Clin Anaesthesiol, 20, pp.81~99 (2006)
- Park CH, "Sedation methods can determine performance of endoscopic submucosal dissection in patients with gastric neoplasia", SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 27(8), pp.2760~2767 (2013), SPRINGER
- Park CH, "Risk Factors and Prognosis of Pulmonary Complications After Endoscopic Submucosal Dissection for Gastric Neoplasia", DIGESTIVE DISEASES AND SCIENCES, 58(2), pp.540~546 (2013), SPRINGER
- Knape JT, "Guidelines for sedation and", or analgesia by non-anaesthesiology doctors, 2007, pp.24, 563~567
- American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists, "Practice guidelines for sedation and analgesia by non-anesthesiologists", Anesthesiology, 96, pp.1004~1017 (2002)
- Bouillon TW, "Pharmacodynamic interaction between propofol and remifentanil regarding hypnosis, tolerance of laryngoscopy, bispectral index, and electroencephalographic approximate entropy", Anesthesiology, 100, pp.1353~1372 (2004)
- Dahaba AA, "Different conditions that could result in the bispectral index indicating an incorrect hypnotic state", Anesth Analg, 101, pp.765~773 (2005)
- Bürkle H, "Remifentanil: a novel, short-acting, mu-opioid", Anesth Analg, 83, pp.646~651 (1996)
- Struys MM, "Ability of the bispectral index, autoregressive modelling with exogenous input-derived auditory evoked potentials, and predicted propofol concentrations to measure patient responsiveness during anesthesia with propofol and remifentanil", Anesthesiology, 99, pp.802~812 (2003)
- Zanner R, "Time delay of electroencephalogram index calculation: analysis of cerebral state, bispectral, and Narcotrend indices using perioperatively recorded electroencephalographic signals", Br J Anaesth, 103, pp.394~399 (2009)
- Jian Wu, "The Influence of the Severity of Chronic Virus-Related Liver Disease on Propofol Requirements during Propofol-Remifentanil Anesthesia", Yonsei Medical Journal, 54(1), pp.231~237 (2013), 연세대학교의과대학